REGISTER ON CMA WEBSITE

Join our Virtual Grand Rounds: Gender-Affirming Care on Tuesday, July 9, 2024, from 12:00 to 1:00 p.m. PT.

As gender-affirming care takes the spotlight on the national scene, with restrictions being placed on physicians' ability to provide care in some states, what is the landscape in California? Please join us as we discuss gender health equity with leaders from the California Department of Public Health and physicians involved in gender-affirming care.

James Watt, M.D. will provide us with the current status of COVID-19 and other summer epidemiology updates.

Featured Speakers:

		James Watt, M.D. MPH., Assistant Deputy Director, California Department of Public Health, Center of Infectious Diseases
		Jason Tescher, Manager, Gender Health Equity Section, Office of Health Equity, California Department of Public Health

This event will be moderated by Kimberly Newell Green, M.D.

Kimberly Newell Green, M.D., CMA Trustee; Associate Clinical Professor, University of California, San Francisco

As a result of this activity, participants should be able to:

• Summarize the current epidemiology of COVID-19.
• Recognize when to test for Influenza A as surveillance for H5N1 (Avian flu)
• Discuss the status of gender-affirming care in California and nationally.
• Recognize the importance of and be ready to implement sexual orientation and gender preference data collection in practice settings.

Disclosure:

The following speakers disclose no relevant financial relationships with ineligible companies: Kimberly Newell Green, M.D.. Jason Tescher.

James Watt, M.D. has disclosed that he is a stockholder for the following publicly held companies: Bristol Myers Squibb, Eastman Chemical, Procter & Gamble, Becton Dickinson; Abbvie Inc, and Cerevel Therapeutics. These relationships have been mitigated.

All other planners, staff and others involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity has not received commercial support.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the California Medical Association (CMA) and the California Department of Public Health. CMA is accredited by ACCME to provide continuing medical education for physicians.

The California Medical Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the General CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion to ACCME for the purpose of granting ABS credit